Harrow's Investor & Analyst Day Offers Insightful Agenda
Harrow, a significant player in the field of ophthalmic disease management, is preparing to host its Investor & Analyst Day. This event, set to take place in New York, promises to deliver critical insights into the company's business strategy, product portfolio, and the evolving landscape of eye care treatments.
Overview of the Event
The scheduled Investor & Analyst Day is not just a presentation; it’s an opportunity for industry stakeholders to engage directly with Harrow’s leadership. The event will showcase the company's commercial offerings, pipeline developments, and its vision for the future of ocular health treatments.
Key Presentations by Industry Leaders
Attendees can look forward to presentations from both Harrow's executives and esteemed physician thought leaders. These experts will share insights into the changing dynamics of treatments available for various ocular conditions, highlighting the pressing needs of patients that Harrow aims to address.
Notable Physician Speakers
A remarkable lineup of speakers has been organized for this event:
- Paul Karpecki, OD: Dr. Karpecki, an experienced optometrist, brings over thirty years of expertise, particularly in dry eye disease management. His current role as Director at Kentucky Eye Institute and his position as an Associate Professor highlight his influential contributions to the field.
- Raj Patel, MD, MS: Specializing in retinal diseases, Dr. Patel’s extensive training enables him to tackle conditions like macular degeneration and diabetic retinopathy while also pursuing groundbreaking research for novel treatment methods.
- Seenu Hariprasad, MD: As Chair of the Department of Ophthalmology at the University of Chicago, Dr. Hariprasad is recognized as a leader in vitreoretinal surgery and has significantly advanced our understanding of various retinal disorders.
- Maggie Jeffries, MD, FASA: An expert in ophthalmic anesthesia, Dr. Jeffries’ revelations on procedural sedation techniques are invaluable for outpatient centers performing surgeries.
Event Agenda Highlights
The preliminary agenda comprises a range of informative topics, each designed to delve deep into Harrow's business strategies and innovations. Key discussions include:
- Welcome & Opening Remarks: Introduction by Mike Biega, VP of IR and Communications.
- Harrow Overview & Vision: Presentation by Mark L. Baum, Chief Executive Officer.
- Financial Update: Key financial insights from Andrew Boll, President & CFO.
- Pipeline Products and MELT-300 Development: Insights from Amir Shojaei, PharmD, PhD, and Larry Dillaha, MD.
- Commercial Vision and Patient Access: Addressed by Patrick Sullivan and Prashanth Annavajjhala, MD.
- Retina Products Overview: Led by Aly Harrison, VP of Retina Portfolio.
Webcast Availability
For those who cannot attend in person, a live webcast will provide a platform for broader participation. A recording will also be available, ensuring that key discussions reach a wider audience.
About Harrow
Harrow, Inc. is dedicated to transforming the management of ophthalmic diseases in North America. With a robust product lineup targeting conditions including glaucoma, age-related macular degeneration, and corneal diseases, Harrow is committed to enhancing treatment outcomes and patient accessibility. Their focus on generating affordable and effective treatment options positions them as leaders in the field.
Frequently Asked Questions
What is the purpose of the Investor & Analyst Day?
The event aims to provide stakeholders with insights into Harrow's business strategies, product developments, and to foster engagement with the leadership team.
Who are the key speakers at the event?
The event features notable speakers including Dr. Paul Karpecki, Dr. Raj Patel, and Dr. Seenu Hariprasad, who will share their expertise on various ophthalmic topics.
Will the event be accessible online?
Yes, there will be a live webcast available for those unable to attend in person.
What are some topics that will be covered during the event?
The agenda includes discussions on Harrow's pipeline products, financial health, commercial vision, and the company’s overarching strategies for advancing ocular disease management.
How can someone contact Harrow for more information?
Individuals interested in learning more about the event can email Mike Biega at mbiega@harrowinc.com.
